Clinical trial
Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic…
NCT00078806 · Amgen, Industry · Terminated
Key facts
| NCT number | NCT00078806 |
|---|---|
| Title | Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis |
| Official title | A Phase 3 Safety and Efficacy Study of Etanercept In Children With Systemic Onset Juvenile Rheumatoid Arthritis |
| Lead sponsor | Amgen, Industry |
| Collaborators | Immunex Corporation Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Juvenile Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Etanercept, Placebo |
| Enrollment | 19 |
| Start date | Jun 4, 2001 |
| Primary completion | May 6, 2004 |
| Completion | May 6, 2004 |
| First posted | Mar 9, 2004 |
| Last update posted | Sep 25, 2019 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: